The first day will kick off with a keynote presentation by Jennifer Willert, Global Clinical Development Medical Director of ...

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for ...

Long-Term Safety and Efficacy Data Supporting AP01 (Inhaled Pirfenidone) from the ATLAS Open-Label Extension Trial to be ...

The details of the poster presentation sessions and publish-only abstract are listed below. Publish-Only Abstract Title: Impact of HLA Matching on Clinical Outcomes in a Phase 2 Trial of Bria-IMT ...

The company announced 27 abstracts at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting ...

Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, including preclinical data, demonstrating potential for a differentiated efficacy and safety profile ...